Management of Common Problems in Obstetrics and Gynecology
  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

About this book

This practical book provides current and effective evaluation and treatment options currently available for the full spectrum of conditions affecting women. In easy to consume, bite-sized chapters, it ranges from diseases occurring during pregnancy and the perinatal period, through general gynecologic conditions from childhood to old age, gynecologic urology, oncology, reproductive medicine and family planning.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Management of Common Problems in Obstetrics and Gynecology by T. Murphy Goodwin, Martin N. Montoro, Laila Muderspach, Richard Paulson, Subir Roy, T. Murphy Goodwin,Martin N. Montoro,Laila Muderspach,Richard Paulson,Subir Roy in PDF and/or ePUB format, as well as other popular books in Medicine & Gynecology, Obstetrics & Midwifery. We have over one million books available in our catalogue for you to explore.

Information

Chapter 1
Cervical Insufficiency and Cerclage
Bhuvan Pathak, James A. McGregor and T. Murphy Goodwin
Department of Medicine and Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, CA, USA
Introduction
Primary cervical insufficiency (CI) is the preferred term for the clinical findings of cervical shortening (≤ 25 mm), funneling and/or cervical dilation during the second trimester in the absence of cervical trauma or other abnormality. Secondary CI includes cervical change in the setting of prior trauma, frequently with a history of prior preterm births in the absence of clear clinical preterm labor. CI is a complication which affects up to 1% of all pregnancies and up to 8% of pregnancies with a history of recurrent second-trimester loss. Given a lack of consensus on its diagnostic criteria, its etiology, and its treatment, there is much variation in its reported incidence. CI is a potentially preventable cause of second-trimester loss and extreme prematurity, with associated low birthweight and other sequelae. Preterm birth, regardless of its etiology, remains the leading cause of neonatal morbidity and mortality.
Diagnosis
Unfortunately, there is no clear consensus for the diagnosis of CI despite its relatively common occurrence. Recurrent, relatively painless, second-trimester fetal losses or preterm births in the absence of contractions or vaginal bleeding remains the gold standard for diagnosis. Therefore, it is crucial that a careful and thorough obstetric and gynecologic history is taken at the onset of prenatal care. Although this presentation is classic, it is clearly recognized that cervical competence is a continuous variable and cannot simply be categorized as “competent” or “incompetent.” For example, contractions may be present as a late sign of CI after prolonged exposure of the membranes to the vaginal flora. Furthermore, with the increasing use of transvaginal ultrasound, cervical shortening and dilation of the internal os can be recognized prior to the onset of symptoms and even without digital examination of the cervix.
Transvaginal sonography of the cervix can be easily performed as early as 14–16 weeks of gestation, when the lower segment of the uterus is developed well enough to allow reproducible measurements of cervical length and architecture of the internal os. Ultrasound cervical length screening at 18–22 weeks’ gestation has been proposed. A length of less than 25 mm is generally considered shortened and suggestive of CI, although the probability of preterm delivery at a given cervical length varies according to gestational age. Also important is any dynamic change noted after Valsalva or mild fundal pressure, as well as differences in cervical appearance or length between consecutive measurements. Other changes which have been described include dilation and funneling of the internal os.
In nonpregnant patients, several tests including physical examination and ultrasound or radiographic studies are available to facilitate the diagnosis of CI. On physical examination, the easy passage of a number 8 Hagar dilator or a number 15 Pratt dilator is essentially diagnostic of CI. Hysterosalpingography showing dilation of the internal os to greater than 6 mm is also diagnostic of CI. These tests are both inconvenient and of limited diagnostic utility as they often yield equivocal results in patients with an unclear history.
Etiology
Although there are several postulated causes of CI, it is believed that ascending intrauterine infection with inflammation and cervical trauma are the most common causes. Cervical trauma most commonly results from surgical interventions including conization, loop electrosurgical excision procedures, repetitive or second-trimester therapeutic terminations, and obstetric injuries. More than one first-trimester termination or a single second-trimester termination increases the incidence of CI. Obstetric injuries include compression necrosis of the cervix due to a prolonged second stage of labor, and spontaneous as well as iatrogenic lacerations of the cervix such as Duhrssen’s incisions performed during vaginal delivery. Further obstetric injury may include extension of the uterine incision into the cervix at the time of cesarean section.
Congenital defects including mullerian anomalies, exposure to diethylstilbestrol, maternal deficiencies in elastin or collagen polymorphisms are less common causes of CI. Rarely, acquired anatomic defects such as large polyps or cervical myomata may be associated with CI. Premature signaling of “cervical ripening,” molecular signals from fetal, trophoblast or maternal sources, is increasingly studied and may explain inconsistent CI in consecutive pregnancies in the same mother.
Management
Once a diagnosis of CI has been established or the need for intervention is identified, treatment has traditionally been by surgical correction using an encircling or cerclage suture. The most commonly used technique is the McDonald cerclage, which was described in 1957. With this, a purse-string suture of four or five bites is placed around the cervix. The material most commonly used is 5 mm Mersilene tape. Mersilene provides better tensile strength and is less likely to pull through the cervix in later gestation. Prolene and nylon are both more easily passed through the cervical tissue but are also more likely to pull through the tissues, given their smaller calibers. The suture is placed below the level of the internal os and must be placed deep into the substance of the cervix to prevent lacerations. The lateral blood supply should be left outside the purse-string suture. The knot is then placed anteriorly and one end left long enough to facilitate removal at 36–37 weeks’ gestation. The McDonald technique differs from the modified Shirodkar cerclage described below in that more suture is left exposed within the vagina.
The Shirodkar cerclage was described 2 years earlier in 1955, using maternal fascia lata as the suture material. Today, a 5 mm Mersilene tape is again the suture material most commonly used. The modified Shirodkar has now replaced the original version due to it simplicity. Transverse incisions are made in the cervix anteriorly and posteriorly, and the suture is passed between the fibromuscular substance of the cervix and the lateral blood supply. The knot is again tied anteriorly and some surgeons anchor the tape anteriorly and/or posteriorly to the cervical tissue using a second suture to avoid slippage of the tape. While the originally described Shirodkar cerclage requires increased dissection of both the bladder and rectum superiorly, as well as entailing increased operative time, bleeding, cervical scarring, and cesarean delivery rates, the modified Shirodkar avoids these complications. The Shirodkar is less commonly employed but may still be indicated in cases where a previous McDonald cerclage has failed or when the cervix is significantly shortened due to congenital abnormalities or surgical intervention.
In cases where vaginal cerclage has failed or when there is marked scarring, shortening or deformation of the cervix, precluding vaginal placement, transabdominal cerclage may be employed. Given the inherently more invasive nature of the abdominal route, maternal and fetal risks are significantly increased. An abdominal incision is made and the lower uterine segment exposed. The uterine vessels are located and withdrawn laterally, and a Mersilene tape is placed in the avascular space between the retracted vessels and the uterine isthmus. The suture is passed anteriorly and tied anteriorly and overlies the uterosacral ligaments without penetrating the myometrium. Delivery in these cases must be by cesarean section and the cerclage is usually kept in place for subsequent pregnancies. Fetal salvage is reported to be up to 90%. Several cases of abdominal laparoscopic cerclage placement have been described.
Cerclage placement may be performed on an elective or prophylactic basis, as a therapeutic measure or on an emergency basis, often referred to as a “rescue” cerclage. When the obstetric history is diagnostic for CI, as in the patient with classic repetitive, painless dilation described above, a prophylactic cerclage may be placed in the late first trimester, usually after 10 weeks’ gestation. This usually allows for placement after the gestational age at which most inevitable miscarriages would occur. This timing also allows for documentation of fetal viability and exclusion of major malformations and certain lethal anomalies such as anencephaly, which are usually visible in the late first trimester. In cases where the history is suggestive of CI but not clearly diagnostic, there remains controversy as to the ideal management. Examples of patients at a possibly elevated risk of CI are listed in Box 1.1.
There are differing views as to the specific situations in which elective cerclages should be placed. One view is that of the American College of Obstetricians and Gynecologists which recommends that elective cerclage placement based only on historical factors should be confined to patients with three or more otherwise unexplained second-trimester losses or preterm births. It should be noted that even in women with a history of three or more unexplained second-trimester deliveries, there is still an approximately 50% chance of delivering at term without cerclage placement. Other experts suggest confirmation of cervical change using ultrasound surveillance. Severe restriction of activities or bedrest is less effective but is frequently employed after 24 weeks’ gestation.
Box 1.1 Patients at risk of cervical incompetence without a history of incompetence
  • Procedures with no intervening normal pregnancy
  • Cone biopsy or loop excision
  • More than one first-trimester abortion
  • A single second-trimester abortion
  • Spontaneous preterm premature rupture of membranes or preterm birth less than 28 weeks’ gestation
  • Preterm birth at any time in gestation with progress in labor out of proportion to uterine activity
  • Congenital uterine anomaly without prior loss
  • Multiple gestation
Therapeutic or urgent cerclage is often placed in women with a shortened cervix or evidence of funneling on ultrasound. These women are often being assessed by ultrasound due to a history placing them at risk for CI, or symptoms or findings on physical examination placing them at risk. The randomized studies examining cerclage placement in these situations contain small numbers of subjects and have yielded conflicting results. It appears, however, that cerclage may prolong pregnancy in a woman with a shortened cervix who is at high risk for CI based on history as well. In otherwise low-risk patients with a shortened cervix, cerclage placement has not been shown to significantly prevent preterm birth. Bedrest or a modified version of it is commonly employed for women with a shortened cervix who do not undergo cervical cerclage.
Finally, emergency or “rescue” cerclage is sometimes placed in women with advanced cervical dilation although the supporting data are rather limited. These women must be thoroughly evaluated prior to surgical intervention. Most importantly, chorio-amnionitis must be ruled out. There should also be no vaginal bleeding, no rupture of membranes, and a viable fetus with no major anatomic abnormalities visible. There should be no uterine activity or an excellent response to short-term tocolytics. Evaluation includes but is not necessarily limited to physical examination, cultures of the urine, cervix, and vagina, and a complete blood count. If the patient is deemed to be an appropriate candidate for an emergency cerclage, she should be placed on bedrest and broad-spectrum antibiotics for 12–24 hours prior to the procedure. Adequate uterine relaxation, anesthesia, and visualization of the anatomy are key to the successful placement of an emergency cerclage. This is usually attained by the use of spinal anesthesia as well as with uterine relaxants including terbutaline or nitroglycerine. Other techniques to assist in the reduction of possibly protuberant membranes include placing the patient in the Trendelenburg position, and gentle pressure using a 30 cc Foley catheter balloon and/or moistened gauzes on sponge sticks. Some authors even advocate the use of transabdominal amnioreduction to further reduce the bulging membranes. Postsurgical treatment with up to a 3 week course of broad-spectrum antibiotics and short-term prostaglandin synthase inhibitors for 24–48 hours is also recommended.
Prior to or concurrent to any cerclage, the mother should be screened and treated for common genitourinary tract infections including urinary tract infection, bacteriuria, vaginitis, cervicitis, bacterial vaginosis, and prevalent sexually transmitted infections. Optimal results are obtained with perioperative antibiotic use, tocolytics such as calcium channel blockers, prostaglandin synthase inhibitors, and nitroglycerine, and with serial treatments of progesterone.
Overall success rates with cervical cerclage placement vary widely given the wide variation in studies and controls used. Some authors report no differences with or without cerclage placement, while others report infant viability rates of up to 90% following surgical intervention. For emergency cerclage placement, success rates and neonatal survival vary by both gestational age and cervical dilation, with rates ranging from 33% to 83%.
Finally, the use of rigid pessaries, although not common in the United States, is popular in some European countries. These studies are small with poorly described selection criteria.
Complications
Although not an extremely invasive procedure, the risks with cerclage placement include those related to the operative procedure itself, as well as those related to the prevention of possible subsequent preterm birth. The most commonly encountered complications are chorio-amnionitis and rupture of membranes, both of which have increased rates with advancing gestational age. Rupture of membranes is also greater with emergency cerclage than with elective cerclage and occurs up to 45% of the time in the former situation. In cases where there is subsequent rupture of membranes, we feel that cerclages should generally be removed promptly to avoid chorio-amnionitis and its associated maternal and neonatal morbidity. In the well-counseled patient with rupture of membranes at previable or extremely premature gestational ages, the cerclage may be left in place and the patient closely monitored for any signs of chorio-amnionitis. Other complications include intraoperative bleeding which requires transfusion in 6% of transabdominal procedures. An increased risk of hospitalization for preterm labor, as well as an increased use of tocolytics, has been shown with cerclage use. Cervical lacerations at the time of delivery have been noted in 10% of cases, and chronic fistula formation with long-term cerclage placement has also been reported. Finally, cerclage placement in the setting of twins has been associated with a significantly higher incidence of preterm birth and should therefore be avoided.
Once a cerclage has been placed, a baseline ultrasound should be obtained for cervical length. This allows for accurate assessment of any further changes that may present.
Conclusion
As mentioned above, CI is a complication of pregnancy that is not uncommonly encountered. Despite this, there is not always clear consensus as to its diagnostic criteria and management regimens. A thorough obstetric history is therefore of the utmost importance in these situations. Cerclage placement is commonly employed in patients with a classic history of CI on an elective basis, in the patient with a shortened cervix as a therapeutic measure, or in the patient with advanced dilation on an emergency basis. The most common complications of cerclage placement include rupture of membranes and chorio-amnionitis, both of which should be monitored for, with removal of the suture if necessary.
Suggested reading
Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP. Final results of the cervical incompetence prevention randomized ce...

Table of contents

  1. Cover
  2. Contents
  3. Title
  4. Copyright
  5. Preface
  6. Abbreviations
  7. Chapter 1: Cervical Insufficiency and Cerclage
  8. Chapter 2: Preterm Premature Rupture of the Membranes
  9. Chapter 3: Preterm Labor: Diagnosis and Management
  10. Chapter 4: Post-Term Pregnancy
  11. Chapter 5: Multiple Gestations
  12. Chapter 6: Fetal Growth Restriction
  13. Chapter 7: Rhesus Disease and Isoimmunization
  14. Chapter 8: Diagnosis and Management of Macrosomia
  15. Chapter 9: Labor Induction
  16. Chapter 10: Abnormal Labor
  17. Chapter 11: Operative Vaginal Delivery
  18. Chapter 12: Shoulder Dystocia
  19. Chapter 13: Chorio-Amnionitis and Postpartum Endometritis
  20. Chapter 14: Vaginal Birth After Cesarean
  21. Chapter 15: Placenta Previa and Abruptio Placentae
  22. Chapter 16: Placenta Accreta
  23. Chapter 17: Postpartum Hemorrhage
  24. Chapter 18: Fetal Death
  25. Chapter 19: Assessing the Obstetric Role in the Brain-Damaged Newborn
  26. Chapter 20: Lactation Management
  27. Chapter 21: Heart Disease in Pregnancy
  28. Chapter 22: Asthma during Pregnancy
  29. Chapter 23: Thyroid Disease in Pregnancy: Hyperthyroidism
  30. Chapter 24: Thyroid Disease in Pregnancy: Hypothyroidism
  31. Chapter 25: Seizure Disorders and Headaches in Pregnancy
  32. Chapter 26: Anemia and Thrombocytopenia in Pregnancy
  33. Chapter 27: Venous Thromboembolism and Inherited Thrombophilias
  34. Chapter 28: Systemic Lupus Erythematosus and The Antiphospholipid Syndrome
  35. Chapter 29: Urinary Tract Infections in Pregnancy: from Symptomatic Bacteriuria to Pyelonephritis
  36. Chapter 30: Diabetes Mellitus in Pregnancy
  37. Chapter 31: Gastrointestinal Disorders in Pregnancy
  38. Chapter 32: Viral Exposures During Pregnancy
  39. Chapter 33: HIV in Pregnancy
  40. Chapter 34: Trauma in Pregnancy
  41. Chapter 35: Hypertension in Pregnancy
  42. Chapter 36: Nausea and Vomiting of Pregnancy Including Hyperemesis Gravidarum
  43. Chapter 37: The Acute Abdomen During Pregnancy: Ovarian Torsion, Appendicitis
  44. Chapter 38: Mood and Anxiety Disorders
  45. Chapter 39: The Older Gravida
  46. Chapter 40: Obesity in Pregnancy
  47. Chapter 41: Teratogen Exposure in Pregnancy
  48. Chapter 42: Electronic Fetal Monitoring: Definitions and Principles
  49. Chapter 43: Electronic Fetal Monitoring: A Systematic Approach
  50. Chapter 44: Second- and Third-Trimester Obstetric Ultrasound
  51. Chapter 45: Prenatal Screening for Genetic Disorders
  52. Chapter 46: Antepartum Testing
  53. Chapter 47: Preconception Counseling and Reproductive Life Planning
  54. Chapter 48: Fetal Lung Maturation, the Respiratory Distress Syndrome, and Antenatal Steroid Therapy
  55. Chapter 49: Fetal Interventions
  56. Chapter 50: Vulvovaginitis
  57. Chapter 51: Sexually Transmitted Diseases
  58. Chapter 52: Genital Herpes
  59. Chapter 53: Pelvic Infection
  60. Chapter 54: Prevention of Postoperative Surgical Site Gynecologic Infections
  61. Chapter 55: Prepubertal Vulvovaginitis
  62. Chapter 56: Dysmenorrhea
  63. Chapter 57: Chronic Pelvic Pain
  64. Chapter 58: Abnormal and Dysfunctional Bleeding
  65. Chapter 59: Premenstrual Syndrome
  66. Chapter 60: Adnexal Masses
  67. Chapter 61: Ectopic Pregnancy: Diagnosis and Management
  68. Chapter 62: Endoscopic Surgery
  69. Chapter 63: Postsurgical Adhesion Formationand Prevention
  70. Chapter 64: Uterine Leiomyomata
  71. Chapter 65: Breast Disorders
  72. Chapter 66: Rectovaginal Injuries
  73. Chapter 67: Prepubertal Vulvar Lacerations and Hematomas, Labial Adhesions, and Prolapse of the Urethra
  74. Chapter 68: Female Sexual Function and Dysfunction
  75. Chapter 69: Endometriosis
  76. Chapter 70: Urinary Incontinence
  77. Chapter 71: Urinary Tract Injuries
  78. Chapter 72: Fistulae
  79. Chapter 73: Pelvic Organ Prolapse
  80. Chapter 74: Infections of the Lower Urinary Tract
  81. Chapter 75: Voiding Dysfunction
  82. Chapter 76: Painful Bladder Syndrome/Interstitial Cystitis
  83. Chapter 77: Urethral Disorders
  84. Chapter 78: Anal Incontinence
  85. Chapter 79: Preinvasive Disease of the Lower Genital Tract
  86. Chapter 80: Vulvar Carcinoma
  87. Chapter 81: Vaginal Carcinoma
  88. Chapter 82: Cervical Cancer
  89. Chapter 83: Endometrial Hyperplasia: Diagnosis and Management
  90. Chapter 84: Endometrial Carcinoma: Evaluation and Management
  91. Chapter 85: Ovarian Carcinoma: Management
  92. Chapter 86: Special Tumors of the Ovary
  93. Chapter 87: Trophoblastic Neoplasia: Diagnosis and Management
  94. Chapter 88: Precocious Puberty
  95. Chapter 89: Primary Amenorrhea
  96. Chapter 90: Secondary Amenorrhea
  97. Chapter 91: Galactorrhea and Hyperprolactinemia
  98. Chapter 92: Androgen Excess and Hirsutism
  99. Chapter 93: Polycystic Ovarian Syndrome
  100. Chapter 94: Menopause
  101. Chapter 95: Premature Ovarian Failure
  102. Chapter 96: Human Chorionic Gonadotropin and the Diagnosis of Early Pregnancy
  103. Chapter 97: Work-up of Infertility
  104. Chapter 98: Induction of Ovulation
  105. Chapter 99: Male Factor Infertility
  106. Chapter 100: Uterovaginal Anomalies: Diagnosis and Management
  107. Chapter 101: Tubal Factor in Infertility
  108. Chapter 102: Unexplained infertility
  109. Chapter 103: Human In Vitro Fertilization and Related Assisted Reproductive Techniques
  110. Chapter 104: Oocyte Donation and Third Party Parenting
  111. Chapter 105: Fertility Preservation and Oocyte Cryopreservation
  112. Chapter 106: Recurrent Pregnancy Loss
  113. Chapter 107: Combination Oral Contraceptives, Contraceptive Patch and Vaginal Ring: Indications, Contraindications, Formulations, Monitoring
  114. Chapter 108: Noncontraceptive Effects of Combination Oral Contraceptives
  115. Chapter 109: Injectable and Implantable Contraception
  116. Chapter 110: Intrauterine Devices
  117. Chapter 111: Barrier Methods of Contraception
  118. Chapter 112: Fertility Awareness Family Planning Methods
  119. Chapter 113: Emergency Contraception
  120. Chapter 114: Medical Abortifacients
  121. Chapter 115: Complications of Surgical Abortions
  122. Chapter 116: Tubal Sterilization
  123. Index